# üî¨ Glycerol phenylbutyrate Path Analysis Report

*Generated: 2025-12-07 14:00:25*

## 1. Drug Profile

| Property | Value |
|----------|-------|
| **Drug ID** | DB08909 |
| **Drug Name** | Glycerol phenylbutyrate |
| **Type** | drug |

## 2. Path Statistics

| Metric | Value |
|--------|-------|
| **Total Paths** | 100 |
| **Unique Diseases** | 92 |
| **Mean Attention** | 0.5966 |
| **Std Attention** | 0.0771 |
| **Min Attention** | 0.4653 |
| **Max Attention** | 0.7556 |

### Paths by Hop Count

| Hops | Count |
|------|-------|
| 1 | 10 |
| 2 | 400 |
| 3 | 400 |
| 4 | 400 |
| 5 | 400 |

## 3. Path Type Summary

| Path Type | Count | Description |
|-----------|-------|-------------|
| Drug Similarity | 90 | Paths through similar drugs |
| Protein Target | 0 | Paths through protein targets |
| Pathway | 0 | Paths through biological pathways |
| Biological Process | 0 | Paths through biological processes |
| Other | 10 | Other connection types |

### Key Similar Drugs

| Similar Drug | Max Attention | # Diseases |
|--------------|---------------|------------|
| Ethinylestradiol | 0.8443 | 57 |
| Dasatinib | 0.8267 | 10 |
| Ibrutinib | 0.8200 | 2 |
| Pentoxifylline | 0.8133 | 2 |
| Dabigatran etexilate | 0.8129 | 1 |
| Quinidine | 0.7933 | 8 |
| Tamoxifen | 0.7911 | 10 |

## 4. Top 20 Paths (by Combined Score)

### Path #1: citrullinemia

**Path:**
```
[Glycerol phenylbutyrate] --(0.535)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 1 |
| Avg Attention | 0.5350 |
| Combined Score | 0.5350 |
| Confidence | ‚≠ê‚≠ê‚≠ê Medium |

**Node Types:** `drug` ‚Üí `disease`

**Interpretation:**

**Direct prediction**: TxGNN predicts Glycerol phenylbutyrate may treat citrullinemia based on embedding similarity.

---

### Path #2: carbamoyl phosphate synthetase I deficiency disease

**Path:**
```
[Glycerol phenylbutyrate] --(0.533)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 1 |
| Avg Attention | 0.5334 |
| Combined Score | 0.5334 |
| Confidence | ‚≠ê‚≠ê‚≠ê Medium |

**Node Types:** `drug` ‚Üí `disease`

**Interpretation:**

**Direct prediction**: TxGNN predicts Glycerol phenylbutyrate may treat carbamoyl phosphate synthetase I deficiency disease based on embedding similarity.

---

### Path #3: neonatal intrahepatic cholestasis due to citrin deficiency

**Path:**
```
[Glycerol phenylbutyrate] --(0.528)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 1 |
| Avg Attention | 0.5278 |
| Combined Score | 0.5278 |
| Confidence | ‚≠ê‚≠ê‚≠ê Medium |

**Node Types:** `drug` ‚Üí `disease`

**Interpretation:**

**Direct prediction**: TxGNN predicts Glycerol phenylbutyrate may treat neonatal intrahepatic cholestasis due to citrin deficiency based on embedding similarity.

---

### Path #4: adult-onset citrullinemia type I

**Path:**
```
[Glycerol phenylbutyrate] --(0.517)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 1 |
| Avg Attention | 0.5166 |
| Combined Score | 0.5166 |
| Confidence | ‚≠ê‚≠ê‚≠ê Medium |

**Node Types:** `drug` ‚Üí `disease`

**Interpretation:**

**Direct prediction**: TxGNN predicts Glycerol phenylbutyrate may treat adult-onset citrullinemia type I based on embedding similarity.

---

### Path #5: hyperammonemia due to N-acetylglutamate synthase deficiency

**Path:**
```
[Glycerol phenylbutyrate] --(0.516)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 1 |
| Avg Attention | 0.5159 |
| Combined Score | 0.5159 |
| Confidence | ‚≠ê‚≠ê‚≠ê Medium |

**Node Types:** `drug` ‚Üí `disease`

**Interpretation:**

**Direct prediction**: TxGNN predicts Glycerol phenylbutyrate may treat hyperammonemia due to N-acetylglutamate synthase deficiency based on embedding similarity.

---

### Path #6: acute neonatal citrullinemia type I

**Path:**
```
[Glycerol phenylbutyrate] --(0.511)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 1 |
| Avg Attention | 0.5110 |
| Combined Score | 0.5110 |
| Confidence | ‚≠ê‚≠ê‚≠ê Medium |

**Node Types:** `drug` ‚Üí `disease`

**Interpretation:**

**Direct prediction**: TxGNN predicts Glycerol phenylbutyrate may treat acute neonatal citrullinemia type I based on embedding similarity.

---

### Path #7: citrin deficiency

**Path:**
```
[Glycerol phenylbutyrate] --(0.504)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 1 |
| Avg Attention | 0.5044 |
| Combined Score | 0.5044 |
| Confidence | ‚≠ê‚≠ê‚≠ê Medium |

**Node Types:** `drug` ‚Üí `disease`

**Interpretation:**

**Direct prediction**: TxGNN predicts Glycerol phenylbutyrate may treat citrin deficiency based on embedding similarity.

---

### Path #8: hyperargininemia

**Path:**
```
[Glycerol phenylbutyrate] --(0.504)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 1 |
| Avg Attention | 0.5040 |
| Combined Score | 0.5040 |
| Confidence | ‚≠ê‚≠ê‚≠ê Medium |

**Node Types:** `drug` ‚Üí `disease`

**Interpretation:**

**Direct prediction**: TxGNN predicts Glycerol phenylbutyrate may treat hyperargininemia based on embedding similarity.

---

### Path #9: argininosuccinic aciduria

**Path:**
```
[Glycerol phenylbutyrate] --(0.504)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 1 |
| Avg Attention | 0.5039 |
| Combined Score | 0.5039 |
| Confidence | ‚≠ê‚≠ê‚≠ê Medium |

**Node Types:** `drug` ‚Üí `disease`

**Interpretation:**

**Direct prediction**: TxGNN predicts Glycerol phenylbutyrate may treat argininosuccinic aciduria based on embedding similarity.

---

### Path #10: urea cycle disorder

**Path:**
```
[Glycerol phenylbutyrate] --(0.498)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 1 |
| Avg Attention | 0.4978 |
| Combined Score | 0.4978 |
| Confidence | ‚≠ê‚≠ê Low |

**Node Types:** `drug` ‚Üí `disease`

**Interpretation:**

**Direct prediction**: TxGNN predicts Glycerol phenylbutyrate may treat urea cycle disorder based on embedding similarity.

---

### Path #11: familial ovarian cancer

**Path:**
```
[Glycerol phenylbutyrate] --(0.844)--> [Ethinylestradiol] --(0.534)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6890 |
| Combined Score | 0.4872 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Glycerol phenylbutyrate is similar to Ethinylestradiol, which is associated with familial ovarian cancer. This suggests shared therapeutic mechanisms.

---

### Path #12: malignant non-dysgerminomatous germ cell tumor of ovary

**Path:**
```
[Glycerol phenylbutyrate] --(0.844)--> [Ethinylestradiol] --(0.531)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6875 |
| Combined Score | 0.4861 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Glycerol phenylbutyrate is similar to Ethinylestradiol, which is associated with malignant non-dysgerminomatous germ cell tumor of ovary. This suggests shared therapeutic mechanisms.

---

### Path #13: phosphorus metabolism disease

**Path:**
```
[Glycerol phenylbutyrate] --(0.844)--> [Ethinylestradiol] --(0.530)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6871 |
| Combined Score | 0.4858 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Glycerol phenylbutyrate is similar to Ethinylestradiol, which is associated with phosphorus metabolism disease. This suggests shared therapeutic mechanisms.

---

### Path #14: uterine corpus leiomyoma

**Path:**
```
[Glycerol phenylbutyrate] --(0.844)--> [Ethinylestradiol] --(0.529)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6867 |
| Combined Score | 0.4856 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Glycerol phenylbutyrate is similar to Ethinylestradiol, which is associated with uterine corpus leiomyoma. This suggests shared therapeutic mechanisms.

---

### Path #15: intracerebral hemorrhage

**Path:**
```
[Glycerol phenylbutyrate] --(0.813)--> [Dabigatran etexilate] --(0.560)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6863 |
| Combined Score | 0.4853 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Glycerol phenylbutyrate is similar to Dabigatran etexilate, which is associated with intracerebral hemorrhage. This suggests shared therapeutic mechanisms.

---

### Path #16: borderline epithelial tumor of ovary

**Path:**
```
[Glycerol phenylbutyrate] --(0.844)--> [Ethinylestradiol] --(0.528)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6861 |
| Combined Score | 0.4851 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Glycerol phenylbutyrate is similar to Ethinylestradiol, which is associated with borderline epithelial tumor of ovary. This suggests shared therapeutic mechanisms.

---

### Path #17: migraine with or without aura, susceptibility to

**Path:**
```
[Glycerol phenylbutyrate] --(0.844)--> [Ethinylestradiol] --(0.527)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6859 |
| Combined Score | 0.4850 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Glycerol phenylbutyrate is similar to Ethinylestradiol, which is associated with migraine with or without aura, susceptibility to. This suggests shared therapeutic mechanisms.

---

### Path #18: macroglobulinemia

**Path:**
```
[Glycerol phenylbutyrate] --(0.820)--> [Ibrutinib] --(0.551)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6857 |
| Combined Score | 0.4849 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Glycerol phenylbutyrate is similar to Ibrutinib, which is associated with macroglobulinemia. This suggests shared therapeutic mechanisms.

---

### Path #19: anxiety disorder

**Path:**
```
[Glycerol phenylbutyrate] --(0.844)--> [Ethinylestradiol] --(0.527)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6856 |
| Combined Score | 0.4848 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Glycerol phenylbutyrate is similar to Ethinylestradiol, which is associated with anxiety disorder. This suggests shared therapeutic mechanisms.

---

### Path #20: congestive heart failure

**Path:**
```
[Glycerol phenylbutyrate] --(0.844)--> [Ethinylestradiol] --(0.527)--> 
```

| Metric | Value |
|--------|-------|
| Hops | 2 |
| Avg Attention | 0.6857 |
| Combined Score | 0.4848 |
| Confidence | ‚≠ê‚≠ê‚≠ê‚≠ê High |

**Node Types:** `drug` ‚Üí `drug` ‚Üí `disease`

**Interpretation:**

**Drug similarity path**: Glycerol phenylbutyrate is similar to Ethinylestradiol, which is associated with congestive heart failure. This suggests shared therapeutic mechanisms.

---

## 5. Interpretation Guidelines

### Attention Score Scale

| Score Range | Confidence | Interpretation |
|-------------|------------|----------------|
| ‚â• 0.70 | ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Very High | Strong biological relationship |
| 0.60 - 0.70 | ‚≠ê‚≠ê‚≠ê‚≠ê High | Good evidence for connection |
| 0.50 - 0.60 | ‚≠ê‚≠ê‚≠ê Medium | Moderate support |
| 0.40 - 0.50 | ‚≠ê‚≠ê Low | Weak connection |
| < 0.40 | ‚≠ê Very Low | Speculative |

### How to Use This Report

1. **Prioritize high-scoring paths**: Focus on paths with combined scores > 0.45
2. **Validate intermediate nodes**: Cross-reference proteins/drugs with literature
3. **Consider path length**: Shorter paths (2-3 hops) are generally more reliable
4. **Check for known associations**: Some paths may represent known indications

---

*Report generated by TxGNN Path Analysis Pipeline*